LP
ZVRA icon

LMR Partners’s Zevra Therapeutics ZVRA Stock Holding History

LMR Partners’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100,000
Closed -$834K – 1772
2024
Q4 		$834K Buy
100,000
+50,000
+100% +$427K 0.01% 757
2024
Q3 		$347K Buy
+50,000
New +$339K 0.01% 886
2022
Q4 		– Sell
-10,572
Closed -$66K – 1304
2022
Q3 		$66K Hold
10,572
– – ﹤0.01% 1076
2022
Q2 		$47K Buy
+10,572
New +$48.2K ﹤0.01% 1166

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return